Clostridium difficile colitis: recent therapeutical and immunological considerations

Area of Science:

• Microbiology
• Gastroenterology
• Infectious Diseases

Background:

• Clostridium difficile is the primary cause of antibiotic-associated diarrhea and pseudomembranous colitis.
• It is a frequent cause of infectious diarrhea in hospitalized patients, leading to significant morbidity and mortality.
• The pathogenicity is attributed to the production of at least two toxins: toxin A and toxin B.

Purpose of the Study:

• To investigate the etiological role of Clostridium difficile in infectious diarrhea.
• To understand the mechanism of pathogenesis involving Clostridium difficile toxins.
• To highlight the clinical significance of Clostridium difficile infections in healthcare settings.

Main Methods:

• Literature review of studies on Clostridium difficile.
• Analysis of etiological data for infectious diarrhea.
• Review of toxin characterization and in vivo effects.

Main Results:

• Clostridium difficile identified as the main etiological agent of antibiotic-associated diarrhea and pseudomembranous colitis.
• Toxin A (enterotoxin) induces intestinal tissue damage and fluid response.
• Toxin B (cytotoxin) contributes to pathogenesis through an additive in vivo effect.

Conclusions:

• Clostridium difficile infections pose a significant threat to hospitalized patients.
• Understanding the roles of toxin A and toxin B is crucial for managing C. difficile-associated diseases.
• Aggressive diagnosis and treatment are necessary despite high morbidity and mortality rates.